journal article·2006-09

Biomineralization of calcium disilicide in porous polycaprolactone scaffolds

Vladimir V. Seregin, Jeffery L. Coffer

Biomaterials· Volume 27· Issue 27
Publisher page

Abstract

The incorporation of CaSi(2) grains within a polycaprolactone (PCL) framework results in bioactive and biodegradable scaffolds which may be used in bone tissue regeneration. Porous PCL scaffolds were prepared via a combination of salt-leaching and microemulsion methods. To provide markedly different structural environments for the inorganic phase, calcium disilicide powder was either added to a mixed-composition porogen during a given scaffold preparation, or alternatively added to pre-formed scaffolds. Selective fluorescent labeling, scanning electron microscopy (SEM), and energy dispersive X-ray (EDX) analysis were employed to assess scaffold calcification in vitro. The process of CaSi(2)/PCL scaffold calcification under zero bias, during which calcium phosphate growth is significantly dependent on the structural degradation of CaSi(2) grains, has a similar mechanism as the calcium phosphate growth on bioactive glasses/ceramics. The biomineralization of these scaffolds is initiated solely by the silicide phase and can be accelerated by the degradation of the polymer matrix.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Polymer Surface Interaction Studies · Calcium Carbonate Crystallization and Inhibition

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Biomaterials in drug delivery and tissue engineering: one laboratory's experience10.1021/ar9800993 ↗
2. Designing materials for biology and medicine10.1038/nature02388 ↗
3. Bioactive glass and hybrid scaffolds prepared by sol-gel method for bone tissue engineering10.1179/174367605225011034 ↗
4. Novel bioactive materials with different mechanical properties10.1016/S0142-9612(03)00044-9 ↗
5. Design of bioactive bone substitutes based on biomineralization process10.1016/j.msec.2005.01.002 ↗
6. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro10.1002/jbm.a.10399 ↗
7. Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata10.1021/ja012433n ↗
8. Bronzino · 2000
9. Hench · 1993
10. Simple surface modification of poly(ε-caprolactone) to induce its apatite-forming ability10.1002/jbm.a.30397 ↗
11. Electronic and structural properties of CaSi2
12. Bias-assisted in vitro calcification of calcium disilicide growth layers on spark-processed silicon10.1016/j.biomaterials.2006.02.038 ↗
13. Seregin VV. Part I: Fabrication and surface modification of composite biomaterials based on silicon and calcium disilicide; Part II: synthesis and characterization of erbium doped silicon nanocrystals encapsulated by aluminum and zinc oxides. PhD dissertation, Texas Christian University, 2006.
14. Thomson RC, Shung AK, Yaszemski MJ, Mikos AG. Principles of tissue engineering, 2nd ed, polymer scaffold processing. San Diego: Academic Press; 2000.10.1016/B978-012436630-5/50025-8 ↗
15. Alendronate: a review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis10.2165/00003495-199753030-00006 ↗
16. Ten year's experience with alendronate for osteoporosis in postmenopausal women10.1056/NEJMoa030897 ↗
17. Chemically modified calcium phosphates as novel materials for bisphosphonate delivery10.1002/adma.200306340 ↗
18. Novel biomaterials for bisphosphonate delivery10.1016/j.biomaterials.2004.05.019 ↗
19. Bisphosphonate conjugation to proteins as a means to impart bone affinity10.1021/bp990154m ↗
20. Formation and growth of clusters in conventional and new kinds of simulated body fluids10.1002/jbm.a.10426 ↗
21. Preparation of (4-amino-1-hydroxybutylidene) bisphosphonic acid sodium salt, MK-217 (alendronate sodium). An improved procedure for the preparation of 1-hydroxy-1,1-bisphosphonic acids10.1021/jo00130a036 ↗
22. Smith · 1991 · vol. 112
23. Dietary silicon intake and absorption10.1093/ajcn/75.5.887 ↗
24. Bioactive silicon structure fabrication through nanoetching techniques10.1002/adma.19950071215 ↗
25. Silicon: a possible factor in bone calcification10.1126/science.167.3916.279 ↗
26. Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions10.1002/pssa.200306519 ↗
27. Occupied electronic states of CaSi2 and CaSi: soft-X-ray-fluorescence spectroscopy10.1103/PhysRevB.52.4904 ↗
28. Chemical bond and electronic states in calcium silicides: theory and comparison with synchrotron-radiation photoemission10.1103/PhysRevB.40.10194 ↗
29. Electronic and structural properties of superconducting MgB2, CaSi2, and related compounds10.1103/PhysRevB.64.104507 ↗
30. Nanotube bundles from calcium disilicide: a density functional theory study10.1103/PhysRevB.68.075416 ↗
31. Choosing the crystallization path less traveled10.1126/science.1114920 ↗